Phase-II study of docetaxel, estramustine phosphate, and carboplatin in patients with hormone-refractory prostate cancer
PDF
Cite
Share
Request
Article - Comment
VOLUME: 6 ISSUE: 2
P: 36 - 38
June 2007

Phase-II study of docetaxel, estramustine phosphate, and carboplatin in patients with hormone-refractory prostate cancer

Bull Urooncol 2007;6(2):36-38
1. Baskent Üniversitesi Alanya Uygulama Ve Arastirma Merkezi Üroloji Klinigi
2. Mersin Üniversitesi Tip Fakültesi Üroloji Anabilim Dali
No information available.
No information available
PDF
Cite
Share
Request